B cells in clinical transplantation tolerance

Seminars in Immunology

Volumn 24, Issue 2, 2012, Pages 92-95

  Adams, Andrew B ^a   Newell, Kenneth A ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

B cell; Immune regulation; Tolerance; Transplantation

Indexed keywords

B LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; PHENOTYPE; RECIPIENT; REVIEW; TRANSPLANTATION TOLERANCE;

B-LYMPHOCYTES; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; TRANSPLANTATION TOLERANCE;

EID: 84859266539     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2011.08.019     Document Type: Review

References (24)

1. Zarkhin V., Chalasani G., Sarwal M.M. The yin and yang of B cells in graft rejection and tolerance. Transplant Rev (Orlando) 2010, 24:67-78.
2. Stegall M.D., Raghavaiah S., Gloor J.M. The (re)emergence of B cells in organ transplantation. Curr Opin Organ Transplant 2010, 15:451-455.
3. Lamb K.E., Lodhi S., Meier-Kriesche H.U. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011, 11:450-462.
4. Lodhi S.A., Lamb K.E., Meier-Kriesche H.U. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant 2011, 11:1226-1235.
5. Newell K.A. Clinical transplantation tolerance. Semin Immunopathol 2011, 33:91-104.
6. Sykes M. Immune tolerance: mechanisms and application in clinical transplantation. J Intern Med 2007, 262:288-310.
7. Li X.C., Turka L.A. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 2010, 6:577-583.
8. Turka L.A., Newell K.A., Phippard D. Regulatory cells and cell signatures in transplantation tolerance. Curr Opin Immunol 2011, in press.
9. Mauri C., Blair P.A. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol 2010, 6:636-643.
10. Le Texier L., Thebault P., Lavault A., Usal C., Merieau E., Quillard T., et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant 2011, 11:429-438.
11. Chen J., Xu J., Wang Q., Wang T., Sciammas A., Chong A.S. A non-redundant role for IL-10 produced by B cells in the maintenance of murine heart allograft tolerance. Am J Transplant 2011, 11:517.
12. Lai G., Nakayama Y., Burrell B.E., Ding Y., Bromberg J.S. Non-humoral functions of B cells is required for tolerance. Am J Transplant 2011, 11:105.
13. Louis S., Braudeau C., Giral M., Dupont A., Moizant F., Robillard N., et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006, 81:398-407.
14. Iwase H., Kobayashi T., Kodera Y., Miwa Y., Kuzuya T., Iwasaki K., et al. Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation. Transplantation 2011, 91:191-198.
15. Bhorade S.M., Chen H., Molinero L., Liao C., Garrity E.R., Vigneswaran W.T., et al. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation 2010, 90:540-546.
16. Baan C.C., Dijke I.E., Weimar W. Regulatory T cells in alloreactivity after clinical heart transplantation. Curr Opin Organ Transplant 2009, 14:577-582.
17. Brouard S., Mansfield E., Braud C., Li L., Giral M., Hsieh S.C., et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 2007, 104:15448-15453.
18. Newell K.A., Asare A., Kirk A.D., Gisler T.D., Bourcier K., Suthanthiran M., et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010, 120:1836-1847.
19. Sagoo P., Perucha E., Sawitzki B., Tomiuk S., Stephens D.A., Miqueu P., et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010, 120:1848-1861.
20. Pallier A., Hillion S., Danger R., Giral M., Racape M., Degauque N., et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010, 78:503-513.
21. Martinez-Llordella M., Lozano J.J., Puig-Pey I., Orlando G., Tisone G., Lerut J., et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008, 118:2845-2857.
22. Lozano J.J., Pallier A., Martinez-Llordella M., Danger R., Giral M., Londono M.C., et al. Comparison of transcriptional and blood cell phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant 2011, 11:1916-1926.
23. Knechtle S.J., Pascual J., Bloom D.D., Torrealba J.R., Jankowska-Gan E., Burlingham W.J., et al. Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. Am J Transplant 2009, 9:1087-1098.
24. Kirk A.D., Mead S., Xu A., Mehta A., Guasch A., Cheeseman J., et al. Kidney transplantation using alemtuzumab induction and belatacept/sirolimus maintenance therapy. Am J Transplant 2011, 11:45.